ArticleFrontiers in pharmacology2024

Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment.

Ruiming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.